ROCKWELL MEDICAL, INC. Form 8-A12G: Registration of a class of securities under Section 12(g)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-08-30: Form 8-A12G/A; Description 8-A12G/A; Document a19-18069_18a12ga.htm.
- 2005-10-18: Form 8-A12G; Description FORM 8 PURSUANT TO SECTION 12(G); Document k99108e8va12g.txt.
- 1998-01-23: Form 8-A12G; Description FORM 8-A12G.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2019-08-30 | 8-A12G/A | 8-A12G/A | a19-18069_18a12ga.htm | |
| 2005-10-18 | 8-A12G | FORM 8 PURSUANT TO SECTION 12(G) | k99108e8va12g.txt | |
| 1998-01-23 | 8-A12G | FORM 8-A12G |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |